Letko, Brosseau & Associates’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-57,200
| Closed | -$241K | – | 99 |
|
|
2022
Q3 | $241K | Hold |
57,200
| – | – | ﹤0.01% | 92 |
|
|
2022
Q2 | $160K | Hold |
57,200
| – | – | ﹤0.01% | 94 |
|
|
2022
Q1 | $327K | Hold |
57,200
| – | – | ﹤0.01% | 94 |
|
|
2021
Q4 | $522K | Hold |
57,200
| – | – | 0.01% | 93 |
|
|
2021
Q3 | $611K | Hold |
57,200
| – | – | 0.01% | 92 |
|
|
2021
Q2 | $888K | Hold |
57,200
| – | – | 0.01% | 91 |
|
|
2021
Q1 | $927K | Hold |
57,200
| – | – | 0.01% | 88 |
|
|
2020
Q4 | $1.21M | Hold |
57,200
| – | – | 0.02% | 88 |
|
|
2020
Q3 | $848K | Buy |
57,200
+12,200
| +27% | +$181K | 0.01% | 85 |
|
|
2020
Q2 | $662K | Buy |
+45,000
| New | +$662K | 0.01% | 89 |
|